Healio4d
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
How to get the most out of Sticky Notes on Windows 11
To dock the Sticky Notes interface on Windows 11, use these steps: Search for Sticky Notes and click the top result to open ...
Exclusive-ByteDance plans $20 billion capex in 2025, mostly on AI, sources say
ByteDance, the Chinese owner of TikTok, has earmarked over 150 billion yuan ($20.64 billion) in capital expenditure for this ...
brandequity.economictimes.indiatimes2d
ByteDance plans $20 billion capex in 2025, mostly on AI
ByteDance: The main beneficiaries of the spending will be chipmakers Huawei Technologies and Cambricon Technologies plus US ...
조선일보3d
KFDA sets global standard for generative AI medical device approval guidelines
KFDA sets global standard for generative AI medical device approval guidelines Health authority introduces pioneering ...
TikTok's ByteDance plans $20 billion capex in 2025, mostly on AI: Report
The privately held technology giant plans to spend about half of the amount abroad on AI-related infrastructure, primarily ...
Zawya3d
ByteDance plans $20bln capex in 2025, mostly on AI, sources say
The privately held technology giant plans to spend about half of the amount abroad on AI-related infrastructure, primarily ...
ConsumerAffairs5d
FDA approves nasal spray drug to treat depression
Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...